Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, Leicester, Leicestershire, UK.
Department of Cardiology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, CIBER-CV, Madrid, Spain.
Heart. 2021 Sep;107(17):1398-1406. doi: 10.1136/heartjnl-2020-318914. Epub 2021 May 18.
To investigate percutaneous coronary intervention (PCI) practice in an international cohort of patients with spontaneous coronary artery dissection (SCAD). To explore factors associated with complications and study angiographic and longer term outcomes.
SCAD patients (n=215, 94% female) who underwent PCI from three national cohort studies were investigated and compared with a matched cohort of conservatively managed SCAD patients (n=221).
SCAD-PCI patients were high risk at presentation with only 8.8% undergoing PCI outside the context of ST-elevation myocardial infarction/cardiac arrest, thrombolysis in myocardial infarction (TIMI) 0/1 flow or proximal dissections. PCI complications occurred in 38.6% (83/215), with 13.0% (28/215) serious complications. PCI-related complications were associated with more extensive dissections (multiple vs single American Heart Association coronary segments, OR 1.9 (95% CI: 1.06-3.39),p=0.030), more proximal dissections (proximal diameter per mm, OR 2.25 (1.38-3.67), p=0.001) and dissections with no contrast penetration of the false lumen (Yip-Saw 2 versus 1, OR 2.89 (1.12-7.43), p=0.028). SCAD-PCI involved long lengths of stent (median 46mm, IQR: 29-61mm). Despite these risks, SCAD-PCI led to angiographic improvements in those with reduced TIMI flow in 84.3% (118/140). Worsening TIMI flow was only seen in 7.0% (15/215) of SCAD-PCI patients. Post-PCI major adverse cardiovascular and cerebrovascular events (MACCE) and left ventricular function outcomes were favourable.
While a conservative approach to revascularisation is favoured, SCAD cases with higher risk presentations may require PCI. SCAD-PCI is associated with longer stent lengths and a higher risk of complications but leads to overall improvements in coronary flow and good medium-term outcomes in patients.
调查国际自发性冠状动脉夹层(SCAD)患者人群中经皮冠状动脉介入治疗(PCI)的实践情况。探讨与并发症相关的因素,并研究血管造影和长期预后。
研究了来自三个国家队列研究的 215 例接受 PCI 的 SCAD 患者(94%为女性),并将其与 221 例接受保守治疗的 SCAD 患者进行了匹配。
SCAD-PCI 患者在就诊时即存在高风险,仅有 8.8%的患者在 ST 段抬高型心肌梗死/心搏骤停、心肌梗死溶栓治疗(TIMI)0/1 级血流或近端夹层的情况下接受 PCI。215 例患者中有 38.6%(83/215)发生 PCI 并发症,其中 13.0%(28/215)为严重并发症。与 PCI 相关的并发症与更广泛的夹层(多个 vs 单个美国心脏协会冠状动脉节段,OR 1.9[95%CI:1.06-3.39],p=0.030)、更近端的夹层(每毫米近端直径,OR 2.25[1.38-3.67],p=0.001)和真腔无造影剂穿透的夹层(Yip-Saw 2 级与 1 级,OR 2.89[1.12-7.43],p=0.028)相关。SCAD-PCI 涉及的支架长度较长(中位数 46mm,IQR:29-61mm)。尽管存在这些风险,但在 TIMI 血流减少的患者中,84.3%(118/140)的患者实现了血管造影改善。仅在 7.0%(15/215)的 SCAD-PCI 患者中出现 TIMI 血流恶化。PCI 后主要不良心血管和脑血管事件(MACCE)和左心室功能结果良好。
虽然倾向于采用保守的血运重建方法,但高危表现的 SCAD 病例可能需要 PCI。SCAD-PCI 与更长的支架长度和更高的并发症风险相关,但总体上可改善冠状动脉血流,并为患者带来良好的中期预后。